- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Diana Lee Farmer
Total 1212 results
-
Boston VA Research Institute, Inc.Dana-Farber Cancer InstituteCompletedPlasma Cell DisorderUnited States
-
Dana-Farber Cancer InstituteAmerican Society of Clinical OncologyCompletedBreast Cancer | Lung Cancer | Rectal CancerUnited States
-
Beth Israel Deaconess Medical CenterCompletedOvarian Cancer | Peritoneal Cavity CancerUnited States
-
Dana-Farber Cancer InstituteNovartis; Brigham and Women's HospitalCompleted
-
Dana-Farber Cancer InstituteUnknownFanconi's AnemiaUnited States
-
TuHURA Biosciences, Inc.Dana-Farber Cancer Institute; University of Southern California; H. Lee Moffitt... and other collaboratorsActive, not recruitingMerkel Cell Carcinoma | Cutaneous Squamous Cell Carcinoma | Non-Melanoma Skin CancersUnited States
-
Michael WagnerEdgewood Oncology Inc.Not yet recruitingLiposarcoma | MDM2 Gene Amplification | Metastatic Liposarcoma | Unresectable Liposarcoma | Recurrent LiposarcomaUnited States
-
Maximilian Stahl, MDSyndax PharmaceuticalsNot yet recruitingAcute Myeloid Leukemia | Leukemia | AML | AML, Adult | AML With Gene MutationsUnited States
-
Adrienne G. WaksGilead SciencesRecruitingBreast Cancer Female | Breast Cancer Metastatic | Her 2 Positive Breast CancerUnited States
-
Jennifer Crombie, MDGenentech, Inc.RecruitingLymphoma | Lymphoma, Large B-Cell, DiffuseUnited States
-
Reid Merryman, MDGenentech, Inc.RecruitingFollicular Lymphoma | Marginal Zone Lymphoma | Indolent Non-hodgkin LymphomaUnited States
-
Reid Merryman, MDAbbVie; GenmabRecruitingFollicular Lymphoma | Low Grade Non-Hodgkin's Lymphoma, AdultUnited States
-
Jonathan Schoenfeld, MD, MPHNaverisRecruitingHPV Positive Oropharyngeal Squamous Cell Carcinoma | Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC... and other conditionsUnited States
-
Elizabeth Buchbinder, MDGenentech, Inc.RecruitingStage IV Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Unresectable Stage III Cutaneous Melanoma | Unresectable Stage IV Cutaneous MelanomaUnited States
-
Dana-Farber Cancer InstituteThe Leukemia and Lymphoma SocietyRecruitingMyelodysplastic-Myeloproliferative Diseases | Waldenstrom Macroglobulinemia | Smoldering Multiple Myeloma | Chronic Lymphocytic Leukemia (CLL) | Hematological Malignancies | Monoclonal Gammopathy of Undetermined Significance (MGUS) | B-cell Malignancy, Low-grade | Myelodysplastic Syndrome With Low-grade... and other conditionsUnited States
-
Dana-Farber Cancer InstituteAstellas Pharma Inc; Regeneron PharmaceuticalsActive, not recruiting
-
Nancy Lin, MDGenentech, Inc.Active, not recruitingHER2-positive Metastatic Breast Cancer | Central Nervous System MetastasesUnited States
-
Nancy Lin, MDGlaxoSmithKline; NovartisActive, not recruitingBreast CancerUnited States
-
Dana-Farber Cancer InstituteAddario Lung Cancer Medical InstituteActive, not recruiting
-
Dana-Farber Cancer InstituteThe Leukemia and Lymphoma SocietyEnrolling by invitationAcute Myeloid Leukemia | Myelodysplastic Syndromes | Juvenile Myelomonocytic Leukemia | Myeloproliferative NeoplasmUnited States
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer InstituteTerminatedBreast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Estrogen Receptor Positive Breast Cancer | Node-negative Breast CancerUnited States
-
Dana-Farber Cancer InstituteAstraZeneca; National Comprehensive Cancer NetworkActive, not recruitingFatigue | Ovarian Cancer | Coping Behavior | Coping SkillsUnited States
-
Dana-Farber Cancer InstituteBristol-Myers Squibb; Genentech, Inc.CompletedMelanomaUnited States
-
Dana-Farber Cancer InstituteNational Institute on Aging (NIA)CompletedCovid19 | Advanced Care Planning | Shared Decision Making | Advance Directives | Communication Skills | Video Decision Aids | Natural Language ProcessingUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Genentech, Inc.CompletedNon-small Cell Lung CancerUnited States
-
Beth Israel Deaconess Medical CenterWithdrawn
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer InstituteCompletedMalignant MelanomaUnited States
-
Dana-Farber Cancer InstituteNovartis; Brigham and Women's HospitalCompletedMelanoma | Malignant MelanomaUnited States
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical CenterCompleted
-
Joseph AntinMiltenyi Biomedicine GmbHNo longer availableGraft Failure | Delayed Graft Function | Graft-Versus-Host Disease(GVHD) | Anemia Due to Disturbance of Proliferation and/or Differentiation of Hematopoietic Stem CellsUnited States
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical CenterCompleted
-
Dana-Farber Cancer InstituteBayer; Genzyme, a Sanofi CompanyCompleted
-
Dana-Farber Cancer InstituteNovartis; Brigham and Women's HospitalTerminatedHead and Neck CancerUnited States
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical CenterCompleted
-
Dana-Farber Cancer InstituteBrigham and Women's Hospital; AmgenCompletedHematologic MalignanciesUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; H. Lee Moffitt... and other collaboratorsCompleted
-
Eudocia Quant Lee, MDUniversity of California, San Diego; Beth Israel Deaconess Medical Center; Dartmouth-Hitchcock... and other collaboratorsCompletedMalignant GliomaUnited States
-
Dana-Farber Cancer InstituteEMD Serono; National Comprehensive Cancer NetworkRecruitingBladder Cancer | Urothelial Carcinoma | Metastatic Bladder Cancer | Unresectable Bladder CarcinomaUnited States
-
Dana-Farber Cancer InstituteMerck Sharp & Dohme LLC; Gilead SciencesRecruitingBreast Cancer | Triple Negative Breast Cancer | PD-L1 NegativeUnited States
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer Institute; CelgeneRecruitingAcute Myelogenous LeukemiaUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); Pharmavite LLCRecruitingStage, Colon Cancer | Stage I-III Colon Cancer | Stage IV Colon Cancer With Resectable Liver MetastasesUnited States
-
Glenn J. HannaActuate Therapeutics Inc.Active, not recruitingAdenoid Cystic Carcinoma | Metastatic Cancer | Salivary Gland Cancer | Recurrent Salivary Gland CancerUnited States
-
Dana-Farber Cancer InstituteGenentech, Inc.; Stand Up To CancerActive, not recruitingBreast Cancer | Triple Negative Breast Cancer | Circulating Tumor DNA | Residual CancerUnited States
-
Glenn J. HannaSecura Bio, Inc.Active, not recruitingMetastatic Head and Neck Cancer | Advanced Head and Neck Squamous Cell Carcinoma | Recurrent Squamous Cell Carcinoma of the Head and Neck | Squamous Cell Carcinoma of the Head and Neck (SCCHN) | Advanced Head and Neck CancerUnited States
-
Frederick Daniel GrantDana-Farber Cancer InstituteCompleted
-
F. Stephen Hodi, MDMedImmune LLCCompletedMetastatic MelanomaUnited States
-
Dana-Farber Cancer InstituteNational Institute of Nursing Research (NINR)CompletedAcute Myeloid Leukemia (AML)United States
-
Dana-Farber Cancer InstituteNational Institute of Nursing Research (NINR)CompletedProstate CancerUnited States
-
Jazz PharmaceuticalsDana-Farber Cancer Institute; Celerion; LifeWatch Services, Inc.Completed
-
Massachusetts General HospitalDana-Farber Cancer Institute; Infinity Pharmaceuticals, Inc.TerminatedLung Cancer | Stage IV Lung Cancer | Stage IIIb Lung CancerUnited States